Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Anti-PD1 antibodies, activatable anti-PD1 antibodies, and methods of use thereof

Anti-PD1 antibodies, activatable anti-PD1 antibodies, and methods of use thereof

US Patent 10513558 · Granted Dec 24, 2019

Estimated economic value: $3,095,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Activatable anti-CTLA-4 antibodies and uses thereof2025
Modified urokinase-type plasminogen activator polypeptides and methods of use2025
Activatable anti-VEGF scFv2025
Protease-resistant systems for polypeptide display and methods of making and usi2024
Anti-CD40 antibodies and uses thereof2024
Activatable antibodies that bind epidermal growth factor receptor and methods th2024
Anti-CD166 antibodies, activatable anti-CD166 antibodies, and methods of use the2023
Modified urokinase-type plasminogen activator polypeptides and methods of use2023
Matrix metalloprotease-cleavable and serine protease-cleavable substrates and me2023
Matrix metalloprotease-cleavable and serine protease-cleavable substrates and me2023
Matrix metalloprotease-cleavable and serine protease-cleavable substrates and me2022
Anti-CD40 antibodies and uses thereof2022